Biocatalysis for synthesis of pharmaceuticals

Area of Science:

• Pharmaceutical Chemistry
• Biotechnology
• Organic Synthesis

Background:

• Chirality is critical for drug safety and efficacy.
• Producing single enantiomer drugs is a pharmaceutical industry standard.
• Biocatalysis offers high selectivity and purity in chemical transformations.

Purpose of the Study:

• To describe biocatalytic processes for synthesizing chiral pharmaceutical intermediates.
• To highlight the advantages of using enzymes and microorganisms in drug development.

Main Methods:

• Utilizing microorganisms and enzymes (biocatalysts) for chemical transformations.
• Applying biocatalysis for chemo-, regio-, and enantioselective synthesis.
• Focusing on the production of key chiral intermediates.

Main Results:

• Biocatalytic processes yield high purity and high enantiomeric excess of chiral intermediates.
• Demonstrated efficient synthesis of valuable pharmaceutical building blocks.
• Showcased the practical application of biocatalysis in drug development.

Conclusions:

• Biocatalysis is a powerful tool for the enantioselective synthesis of pharmaceutical intermediates.
• Microbial and enzymatic transformations provide sustainable and efficient routes to chiral drugs.
• This methodology supports the development of safer and more effective pharmaceuticals.